Medicamen Organics Ltd (MEDIORG) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

Medicamen Organics Limited was incorporated on March 15, 1995 as ‘Panchdeep Pharmaceuticals Limited’, a public limited company under the Companies Act, 1956, pursuant to a certificate of incorporation dated March 15, 1995 issued by the Registrar of Companies, National Capital Territory (NCT) of Delhi and Haryana. The company has received Certificate of Commencement of Business on March 15, 1995, issued by the Registrar of Companies, National Capital Territory (NCT) of Delhi and Haryana. Subsequently, pursuant to a resolution passed by the Board of Directors in their meeting held on July 31, 1995 and by the Shareholders in their EGM held on October 14, 1995, the name of the Company was changed to ‘Medicamen Organics Limited’ and a fresh certificate of incorporation dated November 14, 1995 was issued by the Registrar of Companies, Delhi and Haryana at Delhi.

Medicamen Organics is engaged in developing, manufacturing and distribution of broad range of pharmaceutical dosage including generic dosage in form of Tablets, Capsules, Oral Liquids, Ointments, Gel, Syrups, Suspension and Dry powders for government (including both state and central governments) and private institutions as contract manufacturer / third party manufacturer. It markets its product to private pharma companies in domestic as well as international markets through third party distributors or on loan license basis. Its products are marketed across India as well as African, CIS and south East Asian Countries like Congo, Benin, Cameg, Togo, Senegal, Burkina Faso, Philippines, Myanmar, Mozambique, Togo, Burundi, Kyrgyzstan and Kenya by its third-party distributor.

Its manufacturing facilities are capable of producing pharmaceutical formulations and products and has fully equipped quality control department with experienced and qualified staff to facilitate smooth manufacturing process. It has in-house testing laboratory and necessary infrastructure to test its raw materials and finished products to match the quality standards. Its core strength lies in product development and documentation, it is regularly engaged in research and development and launching new products. This gives it an exhaustive product list as well as fair pricing in the market. Its product portfolio consists of comprises of wide range of drugs like, Anti-Bacterial, Anti Diarrheal, Anti-Fungal, Anti-Malarial, Anti Diabetic, Proton Pump Inhibitor, Anti Histamine, Anti-Hypertensive drugs, Anti Lipidemic Drug, Anti Parasitic, Multivitamin, Multimineral and Nonsteroidal anti-inflammatory drug (NSAIDS).

Business area of the company

The company is engaged in developing, manufacturing and distribution of broad range of pharmaceutical dosage including generic dosage in form of Tablets, Capsules, Oral Liquids, Ointments, Gel, Syrups, Suspension and Dry powders for government (including both state and central governments) and private institutions as contract manufacturer / third party manufacturer.

Products category

• Capsules
• Ointment/external preparation
• Suspension
• Dry powder sachet
• Tablet

Awards and accreditations

• 2015: ISO 9001:2015 - Manufacture and Supply of Food Supplement for Human use and Non Beta Lactum Tablets, Capsules, Liquid and Ointments (Unit II). 
• 2015: ISO 9001: 2008 Manufacture and Supply of Food Supplement for Human Use (Unit II). 
• 2010: ISO 9001: 2008 (Quality Management System). 
• 2018. ISO 9001:2015 certified company (Unit I) Manufacture and Supply of Tablets, Capsules and Liquid Orals for both Domestic and Export Market.

History and milestones

• 1995: The company was incorporated as a Public Limited company under the name ‘Panchdeep Pharmaceuticals Limited’ and later the company has changed its name from ‘Panchdeep Pharmaceuticals Limited’ to ‘Medicamen Organics Limited’.
• 1996: It started with trading of pharmaceuticals for supplies to various Government departments.
• 1998-2007: It took loan license with ‘M/s Rhydurg Pharmaceuticals’, a unit situated in Kundali across the border of Delhi and started getting product manufactured for its marketing.
• 2007: It purchased a plot of land measuring 1200 square meter from SIDCUL Industrial Authority in Haridwar and started construction for its own pharma unit. The construction of three-storeyed building (including basement measuring 15000 sq. feet was completed and it got its own manufacturing license for tablets, capsules, oral liquids in form 25 and 28 and started its owns production in the same year (UNIT-I).
• 2007: It received WHO/GMP Certificate for Unit I.
• 2010: It applied for a license for manufacturing of food supplements, like protein powders, vitamin tablets and syrups etc. and got its first license.
• 2017: It received WHO/GMP Certificate for Unit I.
• 2017: It got an opportunity to purchase one readymade adjacent unit to shift its food production in a separate unit. It got its first license in this Unit and tied up with renowned Pharma company for one of their renowned products for manufacturing in its plant. This unit was termed as (UNIT-II).
• 2017: It stopped production of general pharma products in Unit-I and converted it into a unit for exclusive production of Iron Tablets because of its huge world-wide demand.